The Campbell's Company Common Stock
Here’s whether The Campbell's Company Common Stock (CPB) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.50% over 10 days); RSI 65 — healthy momentum range; 3-month momentum positive (+16.4%). Concerns: trading below the 200-day MA (long-term downtrend); weak 1-year return of -26.5%. Currently 29.9% off its 52-week high. Score: +1/7.
CPB is trading below its 200-day MA ($24.48) — a key warning sign the longer-term trend is under pressure. An RSI of 64.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -26.5% compares to +20.5% for SPY (trailed the market by 47.0%). The current 29.9% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.